- This topic has 0 replies, 1 voice, and was last updated 9 years, 10 months ago by .
Viewing 1 post (of 1 total)
Viewing 1 post (of 1 total)
- You must be logged in to reply to this topic.
StocksDB › StocksDB › Hawk-Eye On The Stock Markets › Sharda Cropchem Research Report By IDFC Securities
Tagged: IDFC Securities, Sharda Cropchem
Sharda Cropchem (Sharda) is a differentiated model in India’s agrochemicals space with focus on exports (>95% of revenues) and nil investments in manufacturing assets. Sharda seeks to leverage its strong understanding of complex regulatory issues to secure expensive product registrations in regulated markets and cater to this demand through supplies from Chinese vendors. With US$128m sales (83% agrochemical sales) in FY14 and a steadily growing portfolio of new registrations in the EU/ US, we see strong growth ahead for Sharda (25%/24% revenue/ earnings CAGR over FY14-17E; ~27% RoCE in FY17E). We initiate coverage on the stock with Outperformer and a price target of 358.
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Stock Broker Research Reports
Download The Best Broker Research Reports On The Best Stocks